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Abstract
West Nile virus (WNV) has emerged globally as an increasingly important pathogen for humans and domestic animals.
Studies of the evolutionary diversity of the virus over its known history will help to elucidate conserved sites, and
characterize their correspondence to other pathogens and their relevance to the immune system. We describe a large-scale
analysis of the entire WNV proteome, aimed at identifying and characterizing evolutionarily conserved amino acid
sequences. This study, which used 2,746 WNV protein sequences collected from the NCBI GenPept database, focused on
analysis of peptides of length 9 amino acids or more, which are immunologically relevant as potential T-cell epitopes.
Entropy-based analysis of the diversity of WNV sequences, revealed the presence of numerous evolutionarily stable
nonamer positions across the proteome (entropy value of #1). The representation (frequency) of nonamers variant to the
predominant peptide at these stable positions was, generally, low (#10% of the WNV sequences analyzed). Eighty-eight
fragments of length 9–29 amino acids, representing ,34% of the WNV polyprotein length, were identified to be identical
and evolutionarily stable in all analyzed WNV sequences. Of the 88 completely conserved sequences, 67 are also present in
other flaviviruses, and several have been associated with the functional and structural properties of viral proteins.
Immunoinformatic analysis revealed that the majority (78/88) of conserved sequences are potentially immunogenic, while
44 contained experimentally confirmed human T-cell epitopes. This study identified a comprehensive catalogue of
completely conserved WNV sequences, many of which are shared by other flaviviruses, and majority are potential epitopes.
The complete conservation of these immunologically relevant sequences through the entire recorded WNV history suggests
they will be valuable as components of peptide-specific vaccines or other therapeutic applications, for sequence-specific
diagnosis of a wide-range of Flavivivirus infections, and for studies of homologous sequences among other flaviviruses.
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Introduction
West Nile virus (WNV) is a mosquito-borne pathogen of the
family Flaviviridae, genus Flavivirus,closely related to other important
human pathogens, such asyellowfever (YFV),Japaneseencephalitis
(JEV), and dengue (DENV) viruses, among others. The genome is a
single-stranded positive-sense RNA encoding a polyprotein precur-
sor of approximately 3,430 amino acids, which is cleaved into three
structural (capsid, C; precursor membrane and membrane, prM/
M; envelope, E) and seven nonstructural proteins (NS1, 2a, 2b, 3,
4a, 4b and 5) [1,2]. WNV is present predominantly amongst avian
hosts, and can infect humans through incidental zoonotic
transmission via mosquitoes [3]. The virus is endemic in many
parts of Africa, Asia, Europe, and most recently North America [4].
At present, there is no registered human vaccine or specific therapy
to prevent or treat WNV infection. Although the majority of
infected humans remain asymptomatic, about 20% experience
influenza-likesymptoms,andapproximately1in150developsevere
illness, including meningoencephalitis [5,6].
Like other RNA viruses, WNV exhibits significant genetic
diversity, a consequence of mainly high mutation rates in RNA
replication, and subsequent selection of mutants adapted to
changing environment [7,8]. Five distinct genotypes have been
identified by phylogenetic analyses of the C-prM-E region,
differing from each other by 20–25% across the complete genome
[9]. However, variability is uneven across the viral genome, since
mutations detrimental to viral fitness are restricted. Thus, while
certain protein sites permit multiple mutations, sites critical to viral
structure-function are evolutionarily robust and highly conserved.
The analysis of the evolutionary dynamics and immunogenic
properties of these sites has relevance to multiple applications,
including the design of diagnosis, drugs and vaccines.
The focus of this study is to identify and characterize WNV
protein regions that have exhibited strong conservation through-
out the recorded history of the virus, and that are potential targets
of T-cell immune responses. T-cell responses have been implicated
in the control and clearance of WNV infection [10–15]. Their
specificities are governed by human leukocyte antigen (HLA)
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proteins, for presentation to T cells. HLA class I and class II
molecules present peptides to CD8
+ and CD4
+ T-cells respective-
ly, which play a critical role in cytotoxic responses and in the
induction and maintenance of Ag-specific memory responses.
A bioinformatics approach is applied herein to (a) examine the
large number of WNV sequences available in public databases, (b)
analyze the conservation and variability of these sequences, (c)
identify sequence fragments of WNV proteins that are completely
conserved in all known WNVs (henceforth referred to as pan-
WNV sequences), (d) examine the structure-function relationship
and distribution in nature of pan-WNV sequences, and (e) assess
the immune relevance of pan-WNV sequences as potential T-cell
epitopes, correlating immunoinformatic predictions to previously
reported human WNV T-cell epitopes and to our current studies
in the identification of human WNV T-cell epitopes by use of
HLA transgenic mice.
Methods
Methodology overview
The overall bioinformatics approach to this study is summarized
in Figure 1. The rationale for this approach and methodology is
consistent with that of previous studies [16–18], and is briefly
described below.
Data preparation, selection and alignment
WNV sequence records were retrieved from the NCBI Entrez
protein database [19] in June 2007 by searching the NCBI
taxonomy browser for WNV (taxonomy ID 11082).
The sequences of the 10 WNV proteins (C, prM, E, NS1, NS2a,
NS2b, NS3, NS4a, NS4b and NS5) were extracted from the
downloaded records by performing BLAST [20] against the record
sequencesusingthe individual protein sequences as queries,obtained
from the annotated WNV reference record P06935 (Swiss-Prot/
TrEMBL [21]). Multiple sequence alignment of extracted sequences
for each viral protein was performed by use of MUSCLE v3.6 [22].
All multiple sequence alignments were manually inspected and
correctedwherevernecessary.AllextractedWNVproteinsequences,
whether partial or full-length, were included in all analyses, unless
otherwise indicated in the sections below.
In large-scale proteomic analyses such as this study, bias may
result from the collection of redundant sequences, derived from
identical or highly similar WNV isolates sequenced by surveillance
programs. We retained the duplicate sequences (2,206) for our
analysis because they reflect the incidence of the corresponding
WNV isolates in nature and, further, they do not affect the
identification of WNV sequences that are completely (100%)
conserved. As for the highly similar sequences, which may have
been generated from large sequencing projects during single
outbreaks; their removal was deemed undesirable, since such
arbitrary selection would introduce additional bias.
Amino acid difference between WNV protein sequences
Pair-wise percentage amino acid difference for the full-length
unique sequences of each WNV proteins was computed by use of
ClustalW 1.83 [23] with default parameters. This was done to
survey the extent of amino acid variation in the WNV data of 2007.
Nonamer entropy analysis of WNV sequences
Entropy analysis [24,25] was carried out as described in [17], by
use of the Antigenic Variability Analyser tool (AVANA), to study
the diversity of WNV protein sequences over the period which the
sequences were collected. Entropy measurements were based on 9
amino acid peptides (nonamers), since it is the typical length of
epitopes that bind to HLA class I molecules, and of the binding
cores of HLA class II epitopes [26]. At any given position x in the
alignment, nonamer peptide entropy H(x) was calculated by
Hx ðÞ ~{
X nx ðÞ
i~1
pi,xlog2 pi,x ðÞ
where pi,x represents the measured probability of a particular
nonamer peptide i occurring with its center position at x; n(x)
represents the total number of peptides observed at position x – larger
number of peptides generally result in increased entropy values.
Positionswithhighlydominant(conserved)peptidesarecharacterized
Figure 1. General overview of the bioinformatics approach employed in this study.
doi:10.1371/journal.pone.0005352.g001
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sequences, only sequenceswitha valid nonamer centered atposition x
were included in the computation, and positions where more than
50% of sequences contained gaps were discarded for their low
statistical significance. Since peptide entropy is computed at a
nonamer’s center position, the first and last four positions in each
protein alignment are not assigned peptide entropy values. For
sequence sets of finite size, entropy calculations are affected by size
bias, which were corrected by a statistical sub-sampling method, as
described in [17].
Nonamer variant analysis of WNV sequences
Variable amino acid sites were further analyzed by computing
the representation of nonamer variants. At any given position x,
variant nonamers were defined as nonamers that differed by at
least one amino acid from the predominant nonamer (the most
common peptide) at that position. Further details of this analysis
are given in [17].
Identification of completely conserved WNV sequences
Completely conserved sequences (pan-WNV sequences) of at
least 9 amino acids and fully identical in all the sequences analyzed
(100% representation) were identified from the multiple sequence
alignment of each protein. Peptides containing unknown residues
(X) were ignored.
Structure-function analysis of pan-WNV sequences
A literature search was conducted to identify reported and
putativefunctionalpropertiesofthepan-WNVsequences,including
a search of the Prosite database [27] using ScanProsite [28], and a
search of the Pfam database [29]. The conserved sequences were
also mapped onto the three-dimensional (3-D) structures of WNV
proteins whenever these were available in the protein data bank
(PDB) [30]. Only 3-D structures obtained via X-ray diffraction were
utilized for mapping, and were visualized by use of the CPK
representation in the ICM Browser v3.5 (www.molsoft.com).
Identification of pan-WNV sequences common to other
viruses and organisms
Pan-WNV sequences with at least 9 consecutive amino acids in
common with other viruses were identified by performing BLAST
search against protein sequences of all viruses (txid10239) reported
at NCBI (as of August 2007), except WNV (txid11082):
parameters included search by Entrez query limited to ‘‘txi-
d10239[Organism:exp] NOT txid11082[Organism:exp]’’, ‘‘auto-
matically adjust parameters for short sequences’’ option disabled,
‘‘low-complexity’’ filter disabled, maximum number of aligned
sequences to be displayed set to ‘‘20,000’’, expect threshold set to
‘‘200,000’’, or ‘‘20,000’’, or ‘‘2,000’’ until a valid result was
obtained, word size set to ‘‘2’’, matrix set to ‘‘PAM30’’, gap costs
set to ‘‘Existence: 9, Extension: 1’’, compositional adjustments set
to ‘‘no adjustment’’. Similar BLAST searches were carried out
against protein sequences of all organisms, except viruses:
parameters were the same as the previous search against all
viruses, excluding WNV, except that the search by Entrez query
was limited to ‘‘Root[ORGN] NOT Viruses[ORGN] NOT
txid81077[ORGN]’’. Artificial sequence hits were removed by
the ‘‘NOT txid81077[ORGN]’’ keyword.
Identification of known and predicted WNV HLA-
supertype binding epitopes
A literature search and a search of the Immune Epitope
Database [31] (www.immuneepitope.org) identified previously
reported HLA class I and II human T-cell epitopes of WNV that
overlapped at least 9 consecutive amino acids of pan-WNV
sequences. In addition, four prediction models were used to
identify candidate WNV sequences that bind to multiple HLA
class I or II supertype alleles. Putative HLA class I supertype-
restricted peptides were predicted by use of NetCTL [32],
Multipred [33], ARB [34], and class II supertype-restricted
peptides by Multipred and TEPITOPE [35], following the
specifications as described in [17].
Results
WNV protein sequence datasets
A total of 2,746 complete and partial WNV protein sequences
were extracted from the NCBI Entrez protein database records as
of June 2007 (Table 1; Data Set S1). The large number of
sequences analyzed and their wide spatial and temporal (1955–
2005; based on information available in annotated NCBI records)
distribution enabled a broad survey of WNV protein diversity in
nature. The distribution of these sequences varied considerably
among the different proteins (from 141 NS4b sequences to 927 E
sequences). Comparisons of amino acid variation between the full-
length unique sequences of the 10 WNV proteins showed that C
had the highest range of amino acid differences across the
sequences (up to 23%), while NS4b had the lowest (up to 8%)
(Table 1).
Evolutionary stability of WNV
The evolutionary diversity of WNV was studied by computing
entropy as described in the Methods. The entropy plot revealed
the evolutionary variability of nonamer sequences across the WNV
proteome (Figure 2). The vast majority of nonamer positions
exhibited low to moderate entropy (#1.0), indicating lower
probability of mutations occurring over time. Many regions had
zero entropy, signifying no change throughout the recorded
history of the virus. Peak or near peak entropy values (,2) were
observed in the E, NS4a and NS5 proteins. The NS5 protein,
Table 1. Number of WNV protein sequences retrieved from
NCBI and their maximum percentage amino-acid difference.
WNV
protein
Total length
(aa)
b
No. of sequences
analysed
a
% maximum
amino-acid difference
c
C 123 264 23
prM 167 417 19
E 497 927 12
NS1 352 164 16
NS2a 231 143 20
NS2b 131 146 10
NS3 619 146 10
NS4a 149 142 14
NS4b 256 141 8
NS5 905 256 10
Total 3430 2746 -
aRetrieved from NCBI Entrez Protein Database on 28
th June 2007.
bApproximate size indicated in number of amino acids.
cMaximum percentage amino-acid difference for each WNV protein, computed
using ClustalW [23].
doi:10.1371/journal.pone.0005352.t001
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doi:10.1371/journal.pone.0005352.g002
Figure 3. Percentage representation of nonamer variants in relation to the predominant nonamer peptide for all nonamer
positions in WNV protein alignments.
doi:10.1371/journal.pone.0005352.g003
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had the highest percentage of completely conserved nonamer
regions, but also exhibited high entropy in regions at the C-
terminal of the protein. Overall, entropy analysis revealed
numerous highly conserved and evolutionarily stable WNV
sequences distributed throughout the viral proteins, indicative of
Table 2. Completely conserved sequence fragments (pan-
WNV sequences) of WNV proteins.
WNV
protein
Length
(aa) Pan-WNV sequence
a
C - None
prM 14 125-ESWILRNPGYALVA-138
10 158-LLLLVAPAYS-167
E 11 1-FNCLGMSNRDF-11
14 104-GCGLFGKGSIDTCA-117
9 293-LKGTTYGVC-301
19 338-SVASLNDLTPVGRLVTVNP-356
12 370-ELEPPFGDSYIV-381
10 417-LGDTAWDFGS-426
12 449-LFGGMSWITQGL-460
NS1 11 58-RSVSRLEHQMW-68
9 114-GWKAWGKSI-122
9 154-EVEDFGFGL-162
10 195-HSDLSYWIES-204
25 209-TWKLERAVLGEVKSCTWPETHTLWG-233
11 276-DFDYCPGTTVT-286
10 313-CRSCTLPPLR-322
10 328-GCWYGMEIRP-337
NS2a 10 4-DMIDPFQLGL-13
15 69-NSGGDVVHLALMATF-83
NS2b 10 1-GWPATEVMTA-10
14 12-GLMFAIVGGLAELD-25
9 32-PMTIAGLMF-40
11 108-SAYTPWAILPS-118
NS3 10 1-GGVLWDTPSP-10
10 20-TGVYRIMTRG-29
10 52-TTKGAALMSG-61
10 63-GRLDPYWGSV-72
10 74-EDRLCYGGPW-83
12 108-NVQTKPGVFKTP-119
12 131-PTGTSGSPIVDK-142
13 145-DVIGLYGNGVIMP-157
11 161-YISAIVQGERM-171
12 191-VLDLHPGAGKTR-202
9 235-ALRGLPIRY-243
27 256-EIVDVMCHATLTHRLMSPHRVPNYNLF-282
14 288-HFTDPASIAARGYI-301
12 310-AAAIFMTATPPG-321
10 337-QTEIPDRAWN-346
10 357-GKTVWFVPSV-366
16 385-QLNRKSYETEYPKCKN-400
11 408-TTDISEMGANF-418
11 422-RVIDSRKSVKP-432
11 451-TAASAAQRRGR-461
16 470-GDEYCYGGHTNEDDSN-485
9 487-AHWTEARIM-495
11 526-LRGEERKNFLE-536
9 540-TADLPVWLA-548
WNV
protein
Length
(aa) Pan-WNV sequence
a
10 563-WCFDGPRTNT-572
NS4a 15 19-KTWEALDTMYVVATA-33
11 43-ALEELPDALQT-53
13 101-GTKIAGMLLLSLL-113
20 115-MIVLIPEPEKQRSQTDNQLA-134
NS4b 9 39-PATAWSLYA-47
13 68-TSLTSINVQASAL-80
9 85-RGFPFVDVG-93
12 138-AQRRTAAGIMKN-149
10 156-VATDVPELER-165
22 208-VTLWENGASSVWNATTAIGLCH-229
NS5 10 1-GGAKGRTLGE-10
9 60-AKLRWLVER-68
17 79-DLGCGRGGWCYYMATQK-95
22 107-GPGHEEPQLVQSYGWNIVTMKS-128
10 141-DTLLCDIGES-150
10 152-SSAEVEEHRT-161
9 168-VEDWLHRGP-176
16 208-RNPLSRNSTHEMYWVS-223
12 235-MTSQVLLGRMEK-246
10 259-NLGSGTRAVG-268
13 299-NHPYRTWNYHGSY-311
18 318-SASSLVNGVVRLLSKPWD-335
29 340-VTTMAMTDTTPFGQQRVFKEKVDTKAPEP-368
10 375-VLNETTNWLW-384
18 404-KVNSNAALGAMFEEQNQW-421
10 440-EREAHLRGEC-449
12 451-TCIYNMMGKREK-462
29 472-GSRAIWFMWLGARFLEFEALGFLNEDHWL-500
16 504-NSGGGVEGLGLQKLGY-519
13 533-YADDTAGWDTRIT-545
10 548-DLENEAKVLE-557
15 571-IELTYRHKVVKVMRP-585
23 596-ISREDQRGSGQVVTYALNTFTNL-618
12 620-VQLVRMMEGEGV-631
19 662-RMAVSGDDCVVKPLDDRFA-680
14 689-MSKVRKDIQEWKPS-702
18 704-GWYDWQQVPFCSNHFTEL-721
27 741-GRARISPGAGWNVRDTACLAKSYAQMW-767
21 769-LLYFHRRDLRLMANAICSAVP-789
12 792-WVPTGRTTWSIH-803
aNumbers prefixing and affixing sequences represent start and end positions in
the protein alignment.
doi:10.1371/journal.pone.0005352.t002
Table 2. cont.
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emergence.
Representation of variant WNV sequences
Completely conserved nonamer sites with zero variant were
numerous and the occurrence of variant nonamer sequences
across the WNV proteome was generally low, less than 10% of all
WNV recorded sequences at most positions (Figure 3). The
position with the highest representation of variant nonamer
sequences (49%) was found in the nonstructural protein NS4a.
Overall, our data suggest a low probability of immune challenges
from variant WNV T-cell epitopes, due to a high representation of
historically conserved sequences of the WNV proteome in the
known virus data.
Completely conserved pan-WNV sequences
A total of 88 completely conserved sequence fragments (pan-
WNV sequences) were identified across the whole proteome
(Table 2). The length of these fragments ranged from 9 to 29
amino acids, covering a total length of 1,169 amino acids (,34%)
of the complete WNV polyprotein (3,430 aa) (Table 3). The C
protein had no completely conserved nonamer fragment, which is
consistent with the large number of amino acid difference (23%)
observed for sequences of this protein, compared to other WNV
proteins (Table 1). The NS3 and NS5 proteins contained the
greatest number of completely conserved fragments, 25 in NS3
(spanning 48% of the protein length) and 30 in NS5 (spanning
51% of the protein length). The other nonstructural proteins NS1,
NS2a, NS2b, NS4a and NS4b collectively contained a total of 24
completely conserved sequences, covering 11% to 40% of their
respective protein lengths. In contrast, the variability of the
structural proteins was much greater: prM had only two
completely conserved sequences (14% of the protein length),
while E had 7 (18% of the protein length).
Functional and structural analysis of pan-WNV sequences
Sequences conserved throughout the evolutionary history of
rapidly mutating RNA viruses are thought to be critical for
structure and/or function [36]. A search in the Prosite and Pfam
databases [27,29] revealed that 50 of the 88 pan-WNV sequences
are known to be associated with putative or known biological
functions and/or structure (Table 4); the biological significance of
the remaining 38 sequences is still to be determined. In the E
protein, two pan-WNV sequences correspond to the fusion loop
and dimerisation domain [37], while two correspond to immuno-
globulin-like domain, attributed to putative receptor binding sites
[38]. One NS1 sequence correspond to the putative ATP/GTP
binding site p-loop motif, likely to be involved in helicase activity
[39]. NS3 contained 4 pan-WNV sequences that correspond to the
peptidase family S7 (Flavivirus serine protease) domain [40], and 4
that correspond to known/putative Flavivirus Asp-Glu-Ala-Asp/
His (DEAD/H) domain associated with ATP-dependent helicase
activity [41]. NS5 contained 17 sequences that correspond to the
RNA-dependent RNA polymerase (RdRp)/catalytic domain
[42,43]. Furthermore, 33 of the 50 pan-WNV sequences were
predicted to exhibit post-translational modification(s), including N-
glycosylation, protein kinase C (PKC), casein kinase II (CKII) and
tyrosine kinase (TK) phosphorylation, N-myristoylation and/or
amidation.
Amino acid residues exposed and protruding on the surface of
viral proteins are generally subject to fewer packing constraints
and residue interactions as compared to those buried within
protein interiors. Thirty of the 88 pan-WNV sequences could be
mapped on available, but incomplete, WNV protein structures
obtained from the PDB (E protein, 2HG0; NS3, 2IJO; and NS5,
2HFZ) (Figure S1). Five pan-WNV sequences were mostly buried
and an equal number of pan-WNV sequences were partially
exposed (13) or largely exposed (12). These results should be
considered preliminary until full-length 3-D structures are
available.
Distribution of pan-WNV sequences in nature
Sixty-seven (67) of the 88 pan-WNV sequences (,76%)
overlapped at least 9 amino acid sequences of as many as 68
other viruses of the family Flaviviridae, genus Flavivirus (Figure 4).
Each of these 67 sequences matched at least one, and at most 61
Flavivirus species (Figure 5 and Table S1). Murray valley
encephalitis (MVE) virus shared 49 of the 67 pan-WNV
Table 3. Number of pan-WNV sequences, their length in amino acids and percentage coverage of total protein length.
WNV protein Total length (aa)
a Pan-WNV sequences
Number Length (aa) % of total protein length (aa)
b
C 123 0 0 0
prM 167 2 24 14
E 497 7 87 18
NS1 352 8 95 27
NS2a 231 2 25 11
NS2b 131 4 44 34
NS3 619 25 296 48
NS4a 149 4 59 40
NS4b 256 6 75 29
NS5 905 30 464 51
Total 3430 88 1169 34
aApproximate length indicated in number of amino acids, according to the reference protein sequence described in the Methods.
bApproximate percentage rounded off to nearest whole number.
doi:10.1371/journal.pone.0005352.t003
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WNV protein Pan-WNV sequence Functional domains and motifs
a
Putative post-transcriptional
modifications
a
E 1-FNCLGMSNRDF-11 Dimerisation domain PKC, CKII
104-GCGLFGKGSIDTCA-117 Dimerisation domain, Fusion Loop N-myristoylation
293-LKGTTYGVC-301 - N-myristoylation
338-SVASLNDLTPVGRLVTVNP-356 Immunoglobulin-like domain CKII
370-ELEPPFGDSYIV-381 Immunoglobulin-like domain -
417-LGDTAWDFGS-426 - CKII
NS1 58-RSVSRLEHQMW-68 - CKII
114-GWKAWGKSI-122 ATP/GTP-binding site motif A (P-loop) -
209-TWKLERAVLGEVKSCTWPETHTLWG-233 - PKC, CKII
328-GCWYGMEIRP-337 - N-myristoylation
NS2a 69-NSGGDVVHLALMATF-83 - CKII
NS2b 12-GLMFAIVGGLAELD-25 - N-myristoylation
NS3 52-TTKGAALMSG-61 - PKC
74-EDRLCYGGPW-83 Peptidase S7 -
108-NVQTKPGVFKTP-119 Peptidase S7 -
131-PTGTSGSPIVDK-142 Peptidase S7 -
145-DVIGLYGNGVIMP-157 Peptidase S7 N-myristoylation
191-VLDLHPGAGKTR-202 DEAD/H domain N-myristoylation
256-EIVDVMCHATLTHRLMSPHRVPNYNLF-282 DEAD/H domain PKC
288-HFTDPASIAARGYI-301 DEAD/H domain -
310-AAAIFMTATPPG-321 DEAD/H domain -
385-QLNRKSYETEYPKCKN-400 - TK
422-RVIDSRKSVKP-432 - PKC
470-GDEYCYGGHTNEDDSN-485 - CKII, N-myristoylation
NS4a 101-GTKIAGMLLLSLL-113 - N-myristoylation
115-MIVLIPEPEKQRSQTDNQLA-134 - CKII
NS4b 208-VTLWENGASSVWNATTAIGLCH-229 - N-glycosylation, CKII
NS5 1-GGAKGRTLGE-10 - CKII, N-myristoylation
79-DLGCGRGGWCYYMATQK-95 - PKC, N-myristoylation
107-GPGHEEPQLVQSYGWNIVTMKS-128 - PKC
152-SSAEVEEHRT-161 - CKII
208-RNPLSRNSTHEMYWVS-223 - N-glycosylation, CKII
299-NHPYRTWNYHGSY-311 RdRp -
318-SASSLVNGVVRLLSKPWD-335 RdRp -
340-VTTMAMTDTTPFGQQRVFKEKVDTKAPEP-368 RdRp -
375-VLNETTNWLW-384 - N-glycosylation
404-KVNSNAALGAMFEEQNQW-421 RdRp -
451-TCIYNMMGKREK-462 RdRp Amidation
472-GSRAIWFMWLGARFLEFEALGFLNEDHWL-500 RdRp -
504-NSGGGVEGLGLQKLGY-519 RdRp N-myristoylation
533-YADDTAGWDTRIT-545 RdRp -
571-IELTYRHKVVKVMRP-585 RdRp PKC
596-ISREDQRGSGQVVTYALNTFTNL-618 RdRp/ RdRp catalytic domain CKII, N-myristoylation
620-VQLVRMMEGEGV-631 RdRp -
662-RMAVSGDDCVVKPLDDRFA-680 RdRp/ RdRp catalytic domain CKII
689-MSKVRKDIQEWKPS-702 RdRp -
704-GWYDWQQVPFCSNHFTEL-721 RdRp -
Diversity of West Nile Virus
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and representatives of some of the important human pathogens,
St. Louis encephalitis (LEV), DENV, YFV, and tick-borne
encephalitis (TBEV) viruses shared from 36 to 11 of the 67 pan-
WNV sequences. The representation (frequency) of these pan-
WNV sequences ranged from low to high across reported
sequences of the several well studied flaviviruses, including DENV,
JEV, Louping ill (LIV), Omsk hemorrhagic fever (OMSK),
Powassan (PV), LEV, TBEV, and YFV (Table S1). For example,
the pan-WNV sequence E104–117 was present in 99% of the 245 E
protein JEV sequences, while E293–301 was present in only 1% of
the 256 E protein JEV sequences.
Fifty-eight (58) of the 67 pan-WNV sequences shared by other
flaviviruses were from the non-structural proteins. Of the 27 pan-
WNV sequences found in NS5, 10 were present in at least 30
Flavivirus species; while of the 16 sequences in NS3, three were
found in between 25 and 34 other species; The remaining 15
sequences were contained in non-structural proteins NS1 (7),
NS2a (2), NS2b (1), NS4a (3) and NS4b (2). Nine (9) of the 67
pan-WNV sequences shared by flaviviruses originated from the
structural proteins E (7) and prM (2); one of the E protein
sequences was present in 31 species.
Remarkably, 5 of the 88 pan-WNV sequences (prM158–167,
NS3408–418, NS4b208–229, NS51–10, and NS5504–519) shared 9
consecutive amino acids with 7 non-viral species. The nonamer
sequence from prM158–166 is found in the bacterium Acidiphilium
cryptum JF-5; NS3409–417 in the mosquito Aedes albopictus; NS4b218–
226 in the Japanese rice Oryza sativa (japonica cultivar-group);
NS52–10 in the bacterium Actinomyces odontolyticus, NS5504–512 in the
bacteria Burkholderia ambifaria MC40-6 and Burkholderia cepacia
AMMD; and NS506–514 in the bacterium Methylobacterium extorquens
PA1.
Known and predicted HLA supertype-restricted, pan-
WNV T-cell epitopes
A literature survey and IEDB database search revealed that 3 of
the pan-WNV sequences (2 in NS3, and one in NS5) matched 3
WNV protein Pan-WNV sequence Functional domains and motifs
a
Putative post-transcriptional
modifications
a
741-GRARISPGAGWNVRDTACLAKSYAQMW-767 RdRp N-myristoylation
769-LLYFHRRDLRLMANAICSAVP-789 RdRp -
792-WVPTGRTTWSIH-803 RdRp PKC
aProsite (PS) and Pfam (PF) accession numbers: PS00001, N-glycosylation site; PS00005, Protein kinase C phosphorylation (PKC) site; PS00006, Casein kinase II (CKII)
phosphorylation site; PS00007, Tyrosine kinase (TK) phosphorylation site; PS00008, N-myristoylation site; PS00009, Amidation site; PS00017, ATP/GTP-binding site motif
A (P-loop); PS50507, RNA-directed RNA polymerase (RdRp) catalytic domain; PF00869, dimerisation domain; PF00949, Peptidase S7; PF00972, RNA-directed RNA
polymerase (RdRp); PF02832, Immunoglobulin-like domain; PF07652, Flavivirus DEAD/H domain.
doi:10.1371/journal.pone.0005352.t004
Table 4. Reported biological properties of pan-WNV sequences.
Figure 4. Number of pan-WNV sequences conserved in other flaviviruses.
doi:10.1371/journal.pone.0005352.g004
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having HLA restriction (when known), with both class I (B*07) and
II (DR2) specificities (Table 5). Further evaluation of the
immune-relevance of pan-WNV sequences included a search for
putative promiscuous HLA supertype-restricted T-cell epitopes
within these regions by use of NetCTL, Multipred, ARB and
TEPITOPE prediction tools. Seventy-eight (78) of the 88 pan-
WNV sequences (,89%) were predicted to contain 271 supertype-
restricted binding nonamers (Figure 6 and Table S2). Of these
sequences, 62 contained nonamers predicted to bind to multiple
HLA supertypes. Clusters of predicted binders, two or more
overlapping nonamer peptides with identical HLA supertype-
restrictions, known as hotspots [33,44], were found in 41 of the 78
sequences. Seven (7) of the 78 sequences had at least 3 sequential
nonamers overlapping by 8 amino acids. As these sequences are
completely conserved, all of these epitopes are found in all
reported WNV strains.
In addition, 44 pan-WNV sequences were found to contain
sequences of at least 9 amino acids present in 54 CD4
+CD8
2
and/or CD4
2CD8
+ IFN-c ELISpot positive peptides (Table 6),
identified by peptide-specific T-cell responses of murine H-2 class
I or II-deficient transgenic mice, expressing prototypic class I
HLA-A2 (A*0201), -A24 (A*2402) and -B7 (B*0702), and class II
HLA-DR2 (DRB1*1501), -DR3 (DRB1*0301) and -DR4
(DRB1*0401) alleles, and immunized with overlapping peptides
covering the entire WNV proteome (unpublished data of Jung
KO et al., of Johns Hopkins University, Maryland, USA).
Twenty-three (23) of the 44 pan-WNV sequences that overlapped
the ELISpot positive peptides correspond to positive HLA-DR
supertype-restricted T-cell epitope predictions by either Multi-
pred or TEPITOPE (Table 6 and Table S2). The experi-
mental data revealed that 11 out of 44 pan-WNV sequences,
localized in prM, E, NS1, NS3, NS4a, NS4b and NS5, were
promiscuous for at least two HLA-DR alleles; the promiscuity of
9 of these 11 pan-WNV sequences were correctly predicted
(Table S2). In summary, combined with previously reported
data for human WNV T-cell epitopes from literature and public
database (Table 5), at least 44 of the 88 pan-WNV sequences
contained numerous HLA-restricted class I and/or class II
epitopes demonstrated by in vivo T-cell response assays.
Discussion
In the 70 years following the discovery of WNV in Africa in
1937 [45], there has been 100% conservation of 88 pan-WNV
sequences, corresponding collectively to 1169 aa or ,34% of the
3,430 aa total composition of the viral proteome. The remaining
66% of the proteome contained one or more amino acid variants
within each nonamer segment across the reported WNV
sequences. Most of the pan-WNV sequences were found in the
non-structural proteins. Quantitatively, 40% (1058/2643 aa) of
the amino acids of the non-structural proteins (NS1, NS2a, NS2b,
NS3, NS4a, NS4b and NS5) comprised the pan-WNV sequences,
compared to only 14% (111/787 aa) of the structural proteins (C,
prM and E). This marked difference in the evolutionary
conservation/variability of the viral proteins can be attributed to
greater demands on the integrity of nonstructural proteins in their
viral functional roles, and possibly to the selective advantage of
modified structural proteins in the adaptation to host immune
responses. This evolutionary history of the conserved protein
sequences extends to other members of the Flaviviridae family, with
67 of the 88 pan-WNV sequences shared among at least 68 other
flaviviruses. Many of the identified critical biological and/or
structural properties are associated with the conserved sequences;
for example, the E dimerisation domain and fusion loop [37,38],
NS3 peptidase S7, DEAD/H domain [40,41], and NS5 proteins
Figure 5. Number of flaviviruses shared by the pan-WNV sequences.
doi:10.1371/journal.pone.0005352.g005
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doi:10.1371/journal.pone.0005352.g006
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unlikely to significantly diverge in newly emerging WNV isolates
in the future, and represent attractive targets for the development
of diagnostics, specific anti-viral compounds and vaccine candi-
date targets. In short, they can be defined as multi-purpose
immutable, functional and immunological tags of WNV.
It is also noteworthy that 9 consecutive amino acids of 5 of the
pan-WNV sequences are also present in non-viral proteomes, the
Aedes albopictus mosquito, Oryza sativa Japanese rice and several
bacteria. This overlap of pan-WNV sequences with non-viral
sequences is possibly coincidental, but is likely to be statistically
significant as the probability of randomly matching a nonamer is
almost negligible (1/(20
9)). WNV protein sequences found in the
proteomes of bacteria are possibly due to integration of some
unknown virus into the bacterial genome [46,47].. Similarly, the
NS3 nonamer sequence fragment found in the Asian Tiger
mosquito (Aedes albopictus), is possibly due to genetic recombination
between phyla [48]. Unexpectedly, a nonamer of WNV NS4b
protein was found in a single instance within a plant pathogenesis-
related protein from Japanese rice (Oryza sativa), which functions as
plant defense system against pathogens [49].
There is evidence that many of the conserved sequences are
immunologically relevant in humans. Numerous (44/88) con-
tained at least 9 amino acids overlapping with a total of 54
peptides that have been reported to be immunogenic in humans
and/or HLA Tg mice. In addition, putative T-cell epitopes were
predicted by computational analysis for 12 major HLA class I
supertypes and for class II DR supertype, with broad application
to the immune responses of human population worldwide. Some
of the putative T-cell epitopes were predicted to be promiscuous to
multiple HLA supertypes as has been observed with several viruses
[17]. These findings of the limited variability of WNV sequences
relevant to cellular immunity point to the probable success in the
development of a WNV vaccine as compared to the history of
failure of candidate vaccines against the much more highly
variable Flavivirus, such as DENV [17].
A comparison can be made with a similar study of each of the
four DENV serotypes [17]. In contrast to WNV, the sequences
of the combined serotypes of DENV are highly diverse, with only
44 pan-DENV sequences, representing 15% of the proteome
length, that are present in 80% or more of the sequences of each
serotype; only two of these 44 sequences were completely
conserved in all the four serotypes. However, the conservation
and variability of each DENV serotype is comparable to WNV.
The individual DENV serotypes and the WNV show remarkable
stability over the entire recorded history of their sequences, as
demonstrated by their low peptide entropies and variant
frequencies. The pan-WNV sequences matched sequences of
DENV (one or more serotypes) with representations ranging
from low (3%) to high (100%); similar observations were made
for pan-DENV sequences matching WNV sequences (4 to
100%). The conserved sequences that matched with low
representation may pose potential risk of altered ligands resulting
in pathologic immune responses following co-infection or
vaccination and secondary infection with a similar virus. Thus,
while the consequences of such extensive possible cross-reactive
immunity are hypothetical, we propose, for vaccine formulation,
that it is prudent to select conserved sequences that are specific
to the pathogen, and thus representative of a minimal number of
variant sequences.
Supporting Information
Figure S1 The localization of pan-WNV sequences (in purple)
on the three dimensional structure of the respective WNV proteins
(E - 2HG0, NS3 - 2IJO and NS5 - 2HFZ). Abbreviations: (E)
major portion exposed, (P) partially exposed, (B) major portion
buried.
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Table S1 Percentage representation of pan-WNV sequences in
other flaviviruses.
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Table S2 Putative HLA supertype-restricted binding nonamer
peptides in pan-WNV sequences, predicted by immunoinformatics
algorithms (NetCTL, Multipred (MP), ARB and TEPITOPE
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Table 5. WNV sequences with human T-cell epitopes elucidated by other studies.
WNV protein Pan-WNV sequence Reported T-cell epitopes immunogenic in humans
Sequence
a T-cells HLA restriction Reference(s)
b
NS3 145-DVIGLYGNGVIMP-157 VIGLYGNGV CD4 DR2 [50]
256-EIVDVMCHATLTHRLMSPHRVPNYNLF-282 SPHRVPNYNL CD8 B07 [51]
NS5 704-GWYDWQQVPFCSNHFTEL-721 FCSNHFTEL - - 1021472
aEpitope amino acids matching the pan-WNV sequences are underlined.
b1021472 is an accession number of a record in the Immune Epitope Database.
doi:10.1371/journal.pone.0005352.t005
Diversity of West Nile Virus
PLoS ONE | www.plosone.org 11 April 2009 | Volume 4 | Issue 4 | e5352Table 6. Pan-WNV sequences with human T-cell epitopes identified by use of HLA transgenic mice.
WNV protein Pan-WNV sequence
a T-cell epitopes immunogenic in HLA transgenic mice
ELISpot activation peptide
b ELISpot positive HLA transgenic mouse
prM 125-ESWILRNPGYALVA-138
* LVKTESWILRNPGYALVA DR2 & DR4
LRNPGYALVAAVIGWML A24, B7 & DR2
158-LLLLVAPAYS-167
* RVVFVVLLLLVAPAYS A2, DR2, DR3 & DR4
E 104-GCGLFGKGSIDTCA-117
* RGWGNGCGLFGKGSI DR3 & DR4
293-LKGTTYGVC-301
* EKLQLKGTTYGVCSKAFK DR4
370-ELEPPFGDSYIV-381 KVLIELEPPFGDSYIVV DR4
449-LFGGMSWITQGL-460
* FRSLFGGMSWITQGLLGA A2, DR2 & DR3
NS1 209-TWKLERAVLGEVKSCTWPETHTLWG-233
* RLNDTWKLERAVLGEVK DR4
276-DFDYCPGTTVT-286
* EGRVEIDFDYCPGTTVTL DR4
313-CRSCTLPPLR-322 GKLITDWCCRSCTLPPLR DR3 & DR4
328-GCWYGMEIRP-337 SGCWYGMEIRPQRHDEK DR4
NS2a 69-NSGGDVVHLALMATF-83
* FAESNSGGDVVHLALMA DR4
NS2b 1-GWPATEVMTA-10
* GWPATEVMTAVGLMFAIV DR4
108-SAYTPWAILPS-118
* ISAYTPWAILPSVVGFWI A24, B7 & DR4
NS3 1-GGVLWDTPSP-10 GGVLWDTPSPKEYKK B7 & DR4
52-TTKGAALMSG-61 WHTTKGAALMSGEGRL DR3
074-EDRLCYGGPW-083 GSVKEDRLCYGGPWKLQH A2
145-DVIGLYGNGVIMP-157 PIVDKNGDVIGLYGNGVI A2
VIGLYGNGVIMPNGSYI A2
161-YISAIVQGERM-171
* YISAIVQGERMDEPIPA A2 & DR2
191-VLDLHPGAGKTR-202 MLRKKQITVLDLHPGAGK A2 & DR2
VLDLHPGAGKTRRILPQI DR2
235-ALRGLPIRY-243 VAAEMAEALRGLPIRY DR4
EALRGLPIRYQTSAVPR DR4
256-EIVDVMCHATLTHRLMSPHRVPNYNLF-282
* PREHNGNEIVDVMCHATL A2, DR2 & DR4
IVDVMCHATLTHRLMSPH DR2
TLTHRLMSPHRVPNYNLF A2 & DR2
310-AAAIFMTATPPG-321 KVELGEAAAIFMTATPPG A2
337-QTEIPDRAWN-346 LQTEIPDRAWNSGYEWI A2
422-RVIDSRKSVKP-432 EMGANFKASRVIDSRKSV A2
470-GDEYCYGGHTNEDDSN-485 CYGGHTNEDDSNFAHW A2 & DR3
487-AHWTEARIM-495 AHWTEARIMLDNINM A2 & DR3
526-LRGEERKNFLE-536 EYRLRGEERKNFLELLR A2 & DR2
563-WCFDGPRTNT-572
* DRRWCFDGPRTNTIL DR3
NS4a 19-KTWEALDTMYVVATA-33
* HFMGKTWEALDTMYVVA DR2 & DR4
115-MIVLIPEPEKQRSQTDNQLA-134
* VLIPEPEKQRSQTDNQLA DR4
NS4b 39-PATAWSLYA-47 GEFLLDLRPATAWSLYAV DR2
PATAWSLYAVTTAVLTPL DR2 & DR3
68-TSLTSINVQASAL-80
* DYINTSLTSINVQASALF DR3 & DR4
208-VTLWENGASSVWNATTAIGLCH-229
* LITAAAVTLWENGASSVW DR3 & DR4
NS5 107-GPGHEEPQLVQSYGWNIVTMKS-128
* LVQSYGWNIVTMKSGVDV DR3
152-SSAEVEEHRT-161 CDIGESSSSAEVEEHRTI B7
SAEVEEHRTIRVLEMV A2, B7 & DR2
208-RNPLSRNSTHEMYWVS-223
* SRNSTHEMYWVSRASGNV DR2
451-TCIYNMMGKREK-462 ECHTCIYNMMGKREKK A2
472-GSRAIWFMWLGARFLEFEALGFLNEDHWL-500 AKGSRAIWFMWLGARFL A24
WFMWLGARFLEFEALGFL A24
596-ISREDQRGSGQVVTYALNTFTNL-618
* REDQRGSGQVVTYALNTF DR2
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